ETF · iShares
0JGB iShares Biotechnology ETF
ISIN US4642875565London Stock Exchange: 0JGBBlackRock, Inc.
- Healthcare
- ETF
- Distributing
Latest close
LSE$203.60
on
- Ongoing charge
- 0.44% a year
- Fund size
- £8.3bn
As of , at least 15 min delayed
At a glance
As of 20/11/2026, 0JGB (iShares Biotechnology ETF, ISIN US4642875565) closed at $203.60 on the London Stock Exchange. Its ongoing charge is 0.44% a year (about £44 on £10,000). Over the five years to 20/11/2026 its total return was +37.3%, or +7.7% after UK CPIH inflation.
Past returns
- 1 year to 20/11/2026
- +22.9%
- +18.6% after inflation (UK CPIH)
- 3 years to 20/11/2026
- +65.2%
- +48.7% after inflation (UK CPIH)
- 5 years to 20/11/2026
- +37.3%
- +7.7% after inflation (UK CPIH)
£1,000 put in five years ago would have been worth about £1,373 on 20/11/2026 — about £1,077 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.
Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of iShares Biotechnology ETF in pounds (price only, income paid out not included): 2021 +1.5%, 2022 −6.7%, 2023 +0.1%, 2024 +1.1%, 2025 +16.6%; 2026 to 19/11/2026 +23.7%. Returns of iShares Biotechnology ETF in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +41.8%; to 30/09/2025: +3.1%; to 30/09/2024: +8.8%; to 30/09/2023: −4.9%; to 30/09/2022: −9.5%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +23.7% | +19.3% | |
| to | +16.6% | +12.6% | |
| to | +1.1% | −2.4% | |
| +0.1% | −3.9% | ||
| −6.7% | −14.6% | ||
| +1.5% | −3.2% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +41.8% | +36.8% |
| from | +3.1% | −0.9% |
| from | +8.8% | +6.1% |
| from | −4.9% | −10.6% |
| from | −9.5% | −16.9% |
As of , inflation: UK CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
21.1%over 5 years
| 1 year | 19.9% |
|---|---|
| 3 years | 19.5% |
| 5 years | 21.1% |
Annualised from weekly returns. Higher means bumpier.
- Largest fall since November 2021
- −26.4%
- From to
- Lowest 12-month return
- −24.5%
- 12 months to
- Highest 12-month return
- +51.9%
- 12 months to
- Below its highest weekly close since November 2021
- 3.7%
- High of , latest
In words: Volatility of iShares Biotechnology ETF in pounds, annualised from weekly returns to 19/11/2026: 19.9% over 1 year, 19.5% over 3 years, 21.1% over 5 years. Largest fall in the price of iShares Biotechnology ETF since November 2021, in pounds: −26.4% from 26/11/2021 to 17/06/2022. The lowest 12-month return of iShares Biotechnology ETF in pounds (price only, income paid out not included) since December 2020 was −24.5% (12 months to 17/06/2022); the highest was +51.9% (12 months to 03/07/2026). On 19/11/2026 the price of iShares Biotechnology ETF was 3.7% below its highest weekly close since November 2021 (30/10/2026), in pounds.
As of , price only — income paid out is not included
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.44%
- a year
- On £10,000
- £44
- a year, roughly
- Over five years
- £218
- of £10,000, before growth
- 22 charge less
- 0 the same
- 7 charge more
Ongoing charge of iShares Biotechnology ETF 0.44% a year. Compared on 20/11/2026, 7 of the 29 other healthcare funds charge more, 0 the same and 22 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
As of
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
iShares Biotechnology ETF is an exchange-traded fund (ETF) from iShares, launched in 2001.
It tracks the NYSE Biotechnology (TR).
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.44% a year — about £44 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is paid out to holders as cash.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Key facts
- Ticker
- 0JGB
- ISIN
- US4642875565
- Provider
- iShares
- Tracks
- NYSE Biotechnology (TR)
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Distributing, paid quarterly
- Income is paid out to holders as cash.
- Ongoing charge
- 0.44% a year · about £44 on £10,000
- Fund size
- £8.3bn
- Launched
- Domicile
- United States
- Currency hedged
- No
- Price currency
- USD
- Category
- Healthcare
Price chart
Over the last year, the closing price went from $166.00 on 21/11/2025 to $203.60 on 20/11/2026 (+22.7%). The lowest close shown was $161.25 on 27/03/2026 and the highest $216.78 on 30/10/2026.
One close a week. Before 31/07/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded. Price only — income paid out is not included, so the line can end below the total return above.
As of , at least 15 min delayed
Five years of prices, and after inflation
257 weekly closes, from 19/11/2021 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1, 3 and 5 years, from weekly returns in pounds.
With a free accountRolling returns
The full range of 250 rolling 12-month returns since December 2020, and of 151 rolling three-year returns, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since November 2021, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Moves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core MSCI World UCITS ETF, over the three years to 19/11/2026 (154 weeks).
Pro
Pro — currently by invitation
Pro includes moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of 0JGB?
The ongoing charge of 0JGB is 0.44% a year — about £44 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of iShares Biotechnology ETF 0.44% a year. Compared on 20/11/2026, 7 of the 29 other healthcare funds charge more, 0 the same and 22 less (share classes counted once).
What does 0JGB track?
0JGB tracks the NYSE Biotechnology (TR).
Is 0JGB accumulating or distributing?
0JGB is distributing: income is paid out to holders as cash. It pays out quarterly.
What is the ISIN of 0JGB?
The ISIN of 0JGB is US4642875565. An ISIN identifies one exact share class of a fund; 0JGB is its ticker on the London Stock Exchange.
What were 0JGB’s returns in each of the last five years?
Calendar-year returns of 0JGB in pounds (price only, income paid out not included): 2021 +1.5%, 2022 −6.7%, 2023 +0.1%, 2024 +1.1%, 2025 +16.6%; 2026 to 19/11/2026 +23.7%. Past performance is not a guide to future returns.
How has 0JGB done after inflation?
Over the five years to 20/11/2026 0JGB’s total return was +37.3%, or +7.7% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.2bn
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £1.2bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £994m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £847m
- ESIHiShares MSCI Europe Health Care Sector UCITS ETF Accum EUR0.18% a year · £792m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £779m
Fund documents and methods
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.